Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.450,01
-0,69%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Celyad Oncology SA (CYAD) Celyad Oncology SA (CYAD) Notizie

Celyad Oncology SA

CYAD
0,47
0,00 (0,00%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/4/202407:00BWCelyad Oncology publie ses résultats financiers pour l'année..
08/2/202422:01BWCelyad Oncology annonce son intention de mettre fin à ses..
17/1/202412:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202422:01BWCelyad Oncology fait le point sur les activités du quatrième..
21/12/202312:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/12/202322:01BWCelyad Oncology SA : Publication d’une notification de..
15/12/202322:01BWCelyad Oncology: Information on the Total Number of Voting..
04/12/202314:34BWCelyad annonce un changement de direction
30/11/202322:01BWCelyad Oncology SA : Publication d’une notification de..
21/11/202322:00BWCelyad Oncology SA: Publication of a transparency..
15/11/202322:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/11/202322:00BWCelyad Oncology: Information on the Total Number of Voting..
09/11/202307:00BWCelyad Oncology publie ses résultats financiers pour le..
27/10/202319:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/9/202322:01BWCelyad Oncology Announces the Termination of Its American..
18/9/202312:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/9/202322:01BWCelyad Oncology SA: Publication of a Rectified Transparency..
13/9/202312:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/9/202322:01BWCelyad Oncology SA: Publication of a Transparency..
11/9/202312:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/9/202322:01BWCelyad Oncology SA: Publication of a Transparency..
06/9/202312:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/9/202322:00GLOBEInformation on the Total Number of Voting Rights and Shares..
05/9/202312:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/9/202322:00BWCelyad Oncology Présente ses Résultats Financiers pour le..
29/8/202318:00BWCelyad Oncology Receives Approximately EUR 9.8m in Private..
25/8/202312:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/8/202322:00GLOBECelyad Oncology receives approximately EUR 9.8m in private..
15/5/202322:01BWCelyad Oncology annonce la réception d’un avis de radiation..
Apertura: Min: Max:
Chiusura: 0,47

La tua Cronologia

NASDAQ
CYAD
Celyad Oncology
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network